Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medicine Regimen”

470 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 470 results

Not applicableUnknownNCT03827811
What this trial is testing

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
University of Cape Town 625
Post-approval studies (Phase 4)Study completedNCT01694017
What this trial is testing

Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy

Who this might be right for
HIV
Tufts University 68
Large-scale testing (Phase 3)Study completedNCT00933790
What this trial is testing

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Who this might be right for
HIV InfectionPulmonary TB
Tuberculosis Research Centre, India 331
Large-scale testing (Phase 3)Study completedNCT00002122
What this trial is testing

Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Who this might be right for
MycosesMycobacterium Avium-Intracellulare InfectionHIV Infections
Pfizer 720
Large-scale testing (Phase 3)Study completedNCT00363142
What this trial is testing

An Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
GlaxoSmithKline 211
Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Post-approval studies (Phase 4)Study completedNCT00771498
What this trial is testing

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Who this might be right for
HIV InfectionTuberculosis
Oswaldo Cruz Foundation 30
Post-approval studies (Phase 4)Study completedNCT04217967
What this trial is testing

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 211
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Early research (Phase 1)Study completedNCT00000739
What this trial is testing

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00003585
What this trial is testing

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
University of New Mexico 35
Post-approval studies (Phase 4)Looking for participantsNCT07138144
What this trial is testing

Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up

Who this might be right for
HIV Infections
José Antonio Mata Marín 156
Post-approval studies (Phase 4)Study completedNCT04522206
What this trial is testing

An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery

Who this might be right for
Pain, PostoperativeSpine Injuries and DisordersNarcotic Use
NYU Langone Health 44
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Large-scale testing (Phase 3)UnknownNCT01534234
What this trial is testing

Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D

Who this might be right for
Heart Failure NYHA Class III and Ambulatory IV
MicroPort CRM 1,039
Testing effectiveness (Phase 2)Study completedNCT01505114
What this trial is testing

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 594
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Post-approval studies (Phase 4)Study completedNCT00275535
What this trial is testing

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Mayo Clinic 165
Next Page